Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

June 23, 2022

Katholieke Universiteit Leuven describes new TRPM3 antagonists

June 23, 2022

Roche synthesizes new HBV HBsAg and HBeAg inhibitors

June 23, 2022

New P2X purinoceptor 3 antagonists discovered at Chiesi

June 23, 2022

Cardiac myosin inhibitors described by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

June 22, 2022

Chengdu Baiyu Pharmaceutical patents protein mono-ADP-ribosyltransferase TIPARP inhibitors

June 22, 2022

Roche describes new hepatitis B virus HBsAg and HBeAg inhibitors

June 22, 2022

Chengdu Cynogen Bio-Pharmaceutical Technology presents new CDK inhibitors

June 22, 2022

New GLP-1 receptor agonists identified at Shenzhen Salubris Pharmaceuticals

June 22, 2022

New cyclin-dependent kinase inhibitors divulged by Allorion Therapeutics

June 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...